The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets

Papillary renal cell carcinoma (PRCC) accounts for 15–20% of all kidney neoplasms and continually attracts attention due to the increase in the incidents in which it occurs. The molecular mechanism of PRCC remains unclear and the efficacy of drugs that treat PRCC lacks sufficient evidence in clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Jin-Shu, Li, Zhe-Kun, Lin, Peng, Wang, Xiao-Dong, Chen, Gang, Yan, Hai-Biao, Li, Sheng-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412146/
https://www.ncbi.nlm.nih.gov/pubmed/30816528
http://dx.doi.org/10.3892/or.2019.7014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412146/
https://www.ncbi.nlm.nih.gov/pubmed/30816528
http://dx.doi.org/10.3892/or.2019.7014

Ejemplares similares